Larvol Delta - Actuate-Announces-Promising-Preclinical-Data-Showing-Synergistic-Activity-of-Elraglusib-in-Combination-with-RAS-Inhibitors-Zoldonrasib-and-Daraxonrasib

Rasonque (daraxonrasib) - Revolution Medicines

zoldonrasib (RMC-9805) - Revolution Medicines

https://www.biospace.com/press-releases/actuate-announces-promising-preclinical-data-showing-synergistic-activity-of-elraglusib-in-combination-with-ras-inhibitors-zoldonrasib-and-daraxonrasib

Sep 9, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next